BPA for asparlas and oncaspar
Ended Awarded Last action
- Contract number
- 36E79721A0003
- Awardee
-
Servier Pharmaceuticals LLC UEI G3YUU3BJQNL4
- Awarding agency
-
National Acquisition Center
Headquarters, Department of Veterans Affairs
- Task orders
- 3 $55,287 obligated
Award facts
- Opportunity
-
- VA797P12Q0002 Solicitation number
- Combined order value
- $55,287 Current and potential, with all options
- Last date to order 100% complete
- IDV ceiling 1% used
- $10,000,000.00
- Award type
- Single award
- Who can order
- Only the awarding agency
- Contracting staff
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
Award details come from SAM.gov/FPDS.
About this IDV
The U.S. Department of Veterans Affairs (VA) awarded a $10 million Blanket Purchase Agreement (BPA) to Servier Pharmaceuticals LLC, a for-profit pharmaceutical company, to provide the specialty oncology medications asparlas and oncaspar over a five-year period. This single-award BPA was issued against Servier's existing Federal Supply Schedule (FSS) contract for pharmaceuticals and drugs.
The VA has placed several fixed-price call orders against this BPA for delivery of asparlas and oncaspar to VA medical facilities across the country, including locations in Tennessee, California, and Massachusetts. These contracts, valued up to $27,643.58 each, aim to streamline VA's procurement of these critical chemotherapy agents to support cancer treatment programs for veterans. Servier has a history of providing these specialty oncology drugs to the VA through prior BPA and FSS contract awards, demonstrating their ability to reliably supply the required pharmaceuticals.
Task orders
| Task order | Ordering agency | Obligated | Awarded |
|---|---|---|---|
| Oncaspar 750U/ML (PF) INJ, soln,5ML VIL | Veterans Integrated Service Network 22 (VHA) | $27,644 | |
| Pegaspargase(ONCASPAR) | Veterans Integrated Service Network 22 (VHA) | $0 | |
| Asparlas 750 U/ML (PF) injection soln, 5ML vials | Veterans Integrated Service Network 22 (VHA) | $27,644 |
Transactions
| Action | Obligated | Date |
|---|---|---|
| Supplemental Agreement for work within scope | $0 | |
| Exercise an Option | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Exercise an Option | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Exercise an Option | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Exercise an Option | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Original award | $0 |
Quick answers
Who was awarded contract 36E79721A0003?
36E79721A0003 was awarded to Servier Pharmaceuticals LLC by National Acquisition Center (Headquarters) on October 15, 2020.
How much is contract 36E79721A0003 worth?
Orders under 36E79721A0003 have obligated $55,287. 36E79721A0003's own ceiling is $10,000,000.
How many orders have been placed under contract 36E79721A0003?
3 orders have been placed under 36E79721A0003, the latest on August 16, 2021.
Who can order from contract 36E79721A0003?
36E79721A0003 is a single award blanket purchase agreement. Only the awarding agency can place orders on it.
Is contract 36E79721A0003 under another contract?
Yes. 36E79721A0003 is a blanket purchase agreement under 36F79720D0213, a federal supply schedule, on Pharmaceuticals and Drugs (FSS-61-IB).
Was contract 36E79721A0003 competed?
The extent of competition for 36E79721A0003 was full and open competition. The government received 1 offer.
On GovTribe
See this IDV's full record
- Every order and transaction
- The awardee's other awards and teaming partners
- Similar IDVs and recompete opportunities
- Ask GovTribe AI about this IDV